Progress of Apatinib in Treatment of Non-small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the malignant tumor with the highest mortality in China.In recent years, considerable progress has been made in the treatment of NSCLC.The advent of numerous new drugs has significantly improved the survival of patients with advanced NSCLC.Apatinib mesylate is a...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Magazine House of Cancer Research on Prevention and Treatment
2018-11-01
|
| Series: | Zhongliu Fangzhi Yanjiu |
| Subjects: | |
| Online Access: | http://html.rhhz.net/ZLFZYJ/html/8578.2018.18.0504.htm |